What is bepreve?

See the DrugPatentWatch profile for bepreve

What Is Bepreve, and How Does It Compare to Other Medications?

Bepreve is a prescription medication used to treat allergies. It is available in a form called ophthalmic solution, which is applied directly to the eyes to reduce itching, redness, and irritation associated with allergic conjunctivitis.

What Are Its Active Ingredients?

Bepreve contains the active ingredient besifloxacin, a fluoroquinolone antibiotic. This combination of properties allows Bepreve to not only treat allergies but also combat bacterial infections that may be present in the eyes. [1]

Who Makes Bepreve?

The manufacturer of Bepreve is Sun Pharma, a global pharmaceutical company that produces a wide range of medications. On DrugPatentWatch.com, you can find detailed information on Bepreve's patents, pricing, and availability. [2]

What Happens If I Stop Taking Bepreve?

According to its label, the effects of Bepreve typically last for 8-12 hours. Stopping treatment may not significantly impact the underlying allergy; however, it can disrupt treatment of concurrent bacterial infections, making them harder to treat in the long run. [3]

Can I Use Bepreve With Other Medications?

Bepreve is usually safe to use with other eye drops, but it is essential to consult with your doctor or pharmacist first, especially if you are using other ophthalmic medications. Combining Bepreve with other products could amplify certain side effects or interact with the medication's efficacy.

What Are Some Common Side Effects of Bepreve?

Some patients experience eye irritation, tearing, or a sensation of burning when using Bepreve. It's always a good idea to follow your doctor's instructions carefully and report any unusual side effects promptly.

Why Is Bepreve Patent Expiring?

Pharmaceutical companies regularly re-evaluate their patents to decide whether to continue protecting their medication or allow competitors to enter the market. If Bepreve's patent is set to expire, it may make way for biosimilars, generic versions of the medication that can be produced and marketed by other companies.

Sources:

[1] https://www.drugpatentwatch.com/drug/16935/bepreve-ophthalmic-0-5

[2] https://www.drugpatentwatch.com/patent/US10011549B2/bepreve-ophthalmic-0-5

[3] https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c1b3e8e9-e0e4-4b2a-87c8-c8f2a2c7f8d7